These pathways are also involved in MMP-9/Neu-1 cross-talk, highlighting that transactivation of the IR is likely mediated by Neu-1 to promote signaling pathways involved in tumorigenesis, and its downregulation will likely lead to a decrease in cancer viability [231,232,233]. Here, MMP9 is linked to cancer.